Antibodies to staphylococcal enterotoxins and toxic shock syndrome toxin 1 in sera of patients and healthy people in Rio de Janeiro, Brazil.

Journal of Clinical Microbiology
A L Solino NoletoM S Bergdoll

Abstract

Sera from 33 persons with staphylococcal infections and from 37 healthy persons were surveyed for the presence of antibody to staphylococcal enterotoxins A, B, C, D, and E and toxic shock syndrome toxin 1. Thirty-one (93.9%) of the patients and 35 (94.6%) of the control group had antibodies to one or more of the enterotoxins. The numbers of patients with antibody to the enterotoxins were as follows: A, 8; B, 9; C, 7; D, 17; E, 21; and toxic shock syndrome toxin 1, 11. The numbers of healthy individuals with antibody to the enterotoxins were as follows: A, 6; B, 12; C, 8; D, 27; E, 21; and toxic shock syndrome toxin 1, 9.

References

Dec 1, 1974·Applied Microbiology·R RobbinsM Bergdoll
Apr 1, 1971·Applied Microbiology·R V LachicaP D Hoeprich
Apr 1, 1981·The Journal of Infectious Diseases·P M SchlievertR D Nishimura
Apr 1, 1980·Journal of Clinical Microbiology·Z JozefczykM S Bergdoll
Jun 25, 1955·Journal of the American Medical Association·M J SURGALLA, G M DACK

❮ Previous
Next ❯

Citations

Feb 1, 1991·FEMS Microbiology Immunology·J ValleE Gomez-Lucia
Oct 1, 1988·Clinical Microbiology Reviews·J K Todd

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.